fluorobenzenes has been researched along with Hyperkalemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, DG; Dixon, S; Fleet, JL; Gandhi, S; Garg, AX; Gomes, T; Juurlink, D; Kim, R; Li, DQ; Mamdani, M; McArthur, E; Shariff, SZ | 1 |
1 other study(ies) available for fluorobenzenes and Hyperkalemia
Article | Year |
---|---|
Risk of adverse events among older adults following co-prescription of clarithromycin and statins not metabolized by cytochrome P450 3A4.
Topics: Acute Kidney Injury; Aged; Aged, 80 and over; Clarithromycin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Fatty Acids, Monounsaturated; Female; Fluorobenzenes; Fluvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperkalemia; Indoles; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pravastatin; Pyrimidines; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides | 2015 |